This is a StreetInsider.com Premium Only Page

(TBPMF) – Accesswire

Jun 2, 2021 07:30 AM Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting

May 11, 2021 06:30 AM Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain

May 6, 2021 07:30 AM Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial

May 5, 2021 03:00 AM Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios

May 4, 2021 07:30 AM Tetra Bio-Pharma Re-activates Veterinary Clinical Study in Companion Animals

May 3, 2021 06:30 AM Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada

Apr 28, 2021 02:00 AM Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority

Apr 23, 2021 09:00 AM Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial

Apr 15, 2021 02:00 AM Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis

Apr 14, 2021 02:00 AM Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada

Apr 5, 2021 02:00 AM FDA Provides Positive Feedback on Tetra Bio-Pharma's Application for ARDS-003 Clinical Development in COVID-19 Patients

Apr 1, 2021 02:00 AM Tetra Bio-Pharma Receives Second Compliant Rating on Inspection from Health Canada

Mar 30, 2021 02:00 AM Health Canada Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 to be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome

Mar 26, 2021 02:00 AM Tetra Bio-Pharma Initiates Additional Studies on Leading Drug Candidate ARDS-003

Mar 18, 2021 02:00 AM Tetra Bio-Pharma Receives Compliant Rating on Inspection from Health Canada

Mar 15, 2021 02:00 AM Tetra Bio-Pharma Provides Status of Its New Drug Submission Application in Canada

Mar 8, 2021 09:00 AM Correction To Tetra Bio-Pharma News Release Dated February 25th

Mar 3, 2021 07:00 AM Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Feb 25, 2021 07:00 AM Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios

Feb 3, 2021 06:30 AM Tetra Bio-Pharma Creates the ENJOUCA Business Unit

Jan 29, 2021 06:30 AM Tetra Bio-Pharma Announces FDA Clearance on IND, allowing U.S. Reborn1(TM) Clinical Trial to Commence

Dec 30, 2020 06:30 AM Tetra Bio-Pharma Files New Drug Submission for REDUVO(TM) in Canada

Dec 21, 2020 06:30 AM Tetra Bio-Pharma Confirms it is on Track to Receive Government Funding

Dec 16, 2020 06:30 AM Tetra Bio-Pharma Hits Another Milestone Before Year End

Dec 7, 2020 06:30 AM Tetra Bio-Pharma Provides Update on Market Potential for QIXLEEF(TM)

Dec 2, 2020 06:30 AM Tetra Bio-Pharma Completes Major Milestone for COVID-19 Therapeutic

Nov 16, 2020 06:30 AM Tetra Bio-Pharma Provides Update on Recent Milestones

Nov 4, 2020 06:30 AM Tetra Bio-Pharma Provides Update on Market Potential of ARDS-003

Oct 28, 2020 08:00 AM Tetra Bio Pharma Announces Divestiture of Lumiera Health Innovation Inc.

Oct 22, 2020 06:30 AM Tetra Bio-Pharma, Targeted Pharmaceutical & the George Mason University Partner on ARDS-003 to Prevent & Treat COVID-19

Oct 21, 2020 07:00 AM Tetra Bio-Pharma Acquires Exclusive Global Technology Rights to a Mucoadhesive Delivery Technology Called Adversa(R) for its PPP-002 (dronabinol) drug candidate from IntelGenx

Oct 20, 2020 07:30 AM Tetra Bio-Pharma Announces Positive Results in Animal Studies for Treatment of Hyperinflammatory Lung Injury

Oct 7, 2020 08:00 AM Tetra Bio-Pharma Unveils its Commercial Vision on a Robust Chemotherapy Induced Nausea and Vomiting Portfolio

Oct 6, 2020 01:00 PM Tetra Bio-Pharma to Present at Alpha Bronze Virtual Town Hall

Sep 30, 2020 11:40 AM Tetra Bio-Pharma (TBP) Acquires Dronabinol Soft Gel Capsules Exclusive Canadian Distribution Rights to Establish a Strong Commercial Presence in Canada and Accelerate its Profitability

Sep 17, 2020 08:00 AM Tetra Bio-Pharma Adds Two Board Members and Appoints New COO

Sep 11, 2020 09:00 AM Tetra Bio-Pharma Appoints Chief Financial Officer

Sep 4, 2020 08:00 AM Dania Scott Joins Tetra Bio-Pharma as Senior Vice President Commercial Strategy

Sep 2, 2020 08:00 AM Tetra Bio-Pharma Announces Plenitude Clinical Trial is Initiated

Aug 27, 2020 08:00 AM Tetra Bio-Pharma Announces Data on its CBD Metabolite Study in Humans

Aug 18, 2020 08:00 AM Tetra Bio-Pharma Engages Dalton Pharma for GMP Manufacturing of ARDS-003

Aug 17, 2020 08:30 AM Tetra Bio-Pharma and Mondias Enter Into Final Agreement For The Purchase Of Lumiera Health Innovation Inc.

Aug 7, 2020 10:30 AM Tetra Bio-Pharma Virtually Opens the Market

Aug 6, 2020 08:42 AM CORRECTION FROM SOURCE: Tetra Bio-Pharma Provides Update on QIXLEEF(TM)'s European Activities

Aug 6, 2020 08:42 AM CORRECTION FROM SOURCE: Tetra Bio-Pharma Provides Update on QIXLEEF(TM)'s European Activities

Aug 6, 2020 08:00 AM Tetra Bio-Pharma Provides Update on QIXLEEF(TM)'s European Activities

Jul 28, 2020 08:00 AM Tetra Bio-Pharma’s Management Provides Corporate Update on QIXLEEF(TM) & CAUMZ(TM) Drug Development Activities

Jul 27, 2020 08:00 AM Tetra Bio-Pharma Provides Management Update on Pharma Focus

Jul 16, 2020 08:00 AM FDA Provides Positive Feedback on Tetra Bio-Pharma's Pre-Investigational New Drug Application for ARDS-003 to Be Studied in COVID-19 Patients at Risk of Developing Acute Respiratory Distress Syndrome

Jul 15, 2020 08:00 AM Tetra Bio-Pharma Receives Conditional Approval to Graduate to the TSX